Selective antagonism of cJun for cancer therapy
Abstract The activator protein-1 (AP-1) family of transcription factors modulate a diverse range of cellular signalling pathways into outputs which can be oncogenic or anti-oncogenic. The transcription of relevant genes is controlled by the cellular context, and in particular by the dimeric composit...
Main Authors: | Andrew Brennan, James T. Leech, Neil M. Kad, Jody M. Mason |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-020-01686-9 |
Similar Items
-
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
by: Sarah K. Madden, et al.
Published: (2021-01-01) -
A bZIP transcription factor accelerates the transition to reproductive tuber growth and aging in Solanum tuberosum
by: Mason, G.A
Published: (2022) -
Exploring the use of leucine zippers for the generation of a new class of inclusion bodies for pharma and biotechnological applications
by: Ramon Roca-Pinilla, et al.
Published: (2020-09-01) -
Identification of two bZIP transcription factors interacting with the promoter of soybean Rubisco activase gene (GmRCAα)
by: Jinyu eZhang, et al.
Published: (2016-05-01) -
Motif grammar: The basis of the language of gene expression
by: Gergely Nagy, et al.
Published: (2020-01-01)